Start Page

12-13 June 2020   |     Patras, Greece  

Facebook   |     info@evameeting.org 


  FRIDAY, JUNE 21st  
08.00-08.30 Arrival - Badge Collection  

Welcome Message from the Meeting Directors

What is the E.V.A. Meeting About?
08.45-09.30 What is New and Interesting in Dialysis Access?  
  Moderators: K. Katsanos (Greece), D. Karnabatidis (Greece)  
08.45-08.52 The Nephrologist’s view P.R Chaudhury (USA)
08.53-09.00 The Vascular Surgeon’s view D. Shemesh (Israel)
09.01-09.08 The Interventional Radiologist’s view P. Kitrou (Greece)
09.09-09.16 Multi-Disciplinary Meeting for Dialysis Access. Is it Really Needed? Z. Haskal (USA)
09.17-09.30 Discussion
  Panel: J. Tordois (Netherlands), M.A. Twalah (KSA), G. Sengoelge (Austria)  
09.30-10.30 Trial Updates  
  Moderators: D. Karnabatidis (Greece), J.M. Abadal (Spain)  
09.30-09.37 Lutonix United States & Canada PAS SO. Trerotola (USA)
09.38-09.45 The PAVE Study N. Karunanithy (UK)
09.46-09.53 The Lutonix Global AV Registry D. Karnabatidis (Greece)
09.54-10.01 Drug-Coated Balloons for the treatment of Symptomatic Central Venous Stenosis P. Kitrou (Greece)
10.02-10.08 The AVeVA & AVeNEW studies B. Dolmatch (USA)
10.09-10.16 Clinical Trial End Points for Vascular Access P.R Chaudhury (USA)
10.16-10.30 Discussion  
10.30-11.30 Declotting Procedures  
  Moderators: D. Karnabatidis (Greece), B. Dolmatch (USA)  
10.30-11.00 LIVE Case from Patras University Hospital K. Katsanos (Greece)
10.59-11.06 What do the Guidelines Suggest? What are the Options? A. Khwaja (UAE)
11.07-11.14 From Fundamentals to Tips & Tricks M.A. Twalah (KSA)
11.15-11.22 Thrombectomy Devices Have Nothing to Offer N. Karunanithy (UK)
11.23-11.30 Thrombectomy Devices Make the Difference O. Jaffer (UK)
11.30-12.00 Coffee Break  
12.00-12.45 Dialysis Access Treatment Pathway  
  Moderators: D. Karnabatidis (Greece), G. Lampropoulos (Greece)  
12.00-12.07 Dialysis Prevalence Across the Globe L. Balta (Greece)
12.08-12.15 What is a nephrologist expecting from Endovascular Treatment? M. Papasotiriou (Greece)
12.16-12.23 How to get started. What Cases to Pick D. Savio (Italy)
12.24-12.31 Cost Effectiveness K. Katsanos (Greece)
12.31-12.45 Discussion
  Panel: B. Dolmatch (USA), M.Lazarides (Greece), J. Ibeas (Spain)  
12.45-13.30 BD Symposium: AVF Creation with The WavelinQ Procedure  
  Moderators: D. Karnabatidis (Greece), P. Kitrou (Greece)  
  Patient Selection Criteria T. Steinke (Germany)
  Data Update O. Jaffer (UK )
  Mapping and Case Presentation P. Kitrou (Greece)
13.30-14.30 Lunch Break  
14.30-15.15 Central Venous Catheters: Difference Lies in the Details  
  Moderators: O. Jaffer (UK), G. Saracino (Italy)  
  Different Configurations, Different Results? P. Papadimatos (Greece)
  Stenotic central veins. How to approach and treat J. Gilbert (UK)
  Infected CVC. When to remove, how to treat, what to do next G. Sengoelge (Austria)
  Last Option Catheter Access – New Techniques for Tunneling E. Kehagias (Greece)
15.15-16.00 Guidelines Update  
  Moderators: D. Karnabatidis (Greece), J. Tordois (Holland)  
  K-DOQI SO. Trerotola (USA)
  ESVS for Vascular Access J. Tordoir (Netherlands)
  SIR Guidelines Z. Haskal (USA)
  Spanish Guidelines for HD Access J. Ibeas (Spain)
  UK Consensus on Dialysis O. Jaffer (UK)



08.00-09.00 Development in the background  
  Moderators: S. Spiliopoulos (Greece), M. Lazarides (Greece)  
08.00-08.10 Histology and Histopathology of vascular access stenosis G. Sengoelge (Austria)
08.11-08.21 Bio-Engineering J. Lawson (USA)
08.22-08.32 Systemic therapy M. Papasotiriou (Greece)
08.33-08.45 How close are we to a tailored therapy for the HD patient? P.R Chaudhury (USA)
08.45-09.00 Discussion  
09.00-10.00 Drug-Coated Devices. Do we finally have a new tool?  
  Moderator: Karnabatidis (Greece)  
09.00-09.30 LIVE Case from Patras University Hospital P. Kitrou (Greece)
09.31-09.38 Overview of evidence so Far S. Spiliopoulos (Greece)
09.39-09.46 What does the future hold? K. Katsanos (Greece)
09.47-10.00 Discussion  
  Panel: SO. Trerotola (USA), T. Steinke (Germany)  
10.00-11.45 Immature Fistulas – Early Cannulation Grafts  
  Moderators: S. Kakkos (Greece), J. Gilbert (UK)  
10.00-10.07 Immature AVF. A clinical entity. What leads to G. Saracino (Italy)
10.08-10.15 Maturing an Immature Fistula. How to do it? What is the evidence? SO. Trerotola (USA)
10.16-10.23 Early Cannulation Grafts – What do they offer to HD? P.J. Ko (Taiwan)
10.24-10.31 Is there an algorithm to success? J. Lawson (USA)
10.32-10.45 Discussion  
10.45-11.30 Symptomatic Central Venous Stenosis/Occlusion: The last frontier  
  Moderators: D. Savio (Italy) T. Steinke (Germany)  
10.45-10.52 HERO Graft – Recorded Case J. Gilbert (UK)
10.53-11.00 What does Surgical Treatment has to offer? D. Shemesh (Israel)
11.01-11.08 Surfacer – Recorded Case G. Sengoelge (Austria)
11.09-11.16 What do the Guidelines suggest? M. Krokidis (Greece)
11.17-11.23 Endovascular Salvage Procedures for Central Veins. When Enough is Enough? A. Khwaja (UAE)
11.23-11.30 Discussion  
11.30-12.00 Coffee break  
12.00-12.45 Treating the juxta-anastomotic stenosis.  
  Moderators: G. Georgiadis (Greece), K. Katsanos (Greece)  
  Drug-Coated Balloons M. Theofanis (Greece)
  Covered Stents B. Dolmatch (USA)
  Plain Old Balloon – Cutting Balloon Angioplasty J.M. Abadal (Spain)
12.45-13.30 BD Symposium: Vascular Access Management Evidence-Based Solutions  
  Moderators: D. Karnabatidis (Greece), Z. Haskal (USA)  
  The Lutonix® clinical program for the treatment of dysfunctional vascular access SO. Trerotola (USA)
  Covera™ Covered Stent for the Treatment of Fistulas and Grafts B. Dolmatch (USA)
  Treatment Algorithm P. Kitrou (Greece)
  Presentation of Cases K. Katsanos (Greece)
13.30-14.30 Lunch Break  
14.30-16.00 Percutaneous AVF Creation  
  Moderators: P. Kitrou (Greece), TBA  
  WavelinQ – Recorded Case P. Kitrou (Greece)
  Ellipsys – Recorded Case R. Loffroy (France)
  Candidates: How to pick one T. Steinke (Germany)
  What is the experience so far? T. Steinke (Germany)

Endo Vascular Access

Email: info@evameeting.org

Login / Sitemap

© Copyright 2019 - 2021 EVA meeting | Endo Vascular Access